GoldState Music | $500,000,000 | (Apr 22, 2025)
CSignum | $8,021,670 | (Apr 22, 2025)
Terra Security | $7,500,000 | (Apr 22, 2025)
Receptor Life Sciences, Inc.
United States
- Seattle, Washington
- 07/04/2022
- Series A
- $9,700,000
Receptor Life Sciences combines proven drug delivery technologies, compelling therapeutic candidates, and traditional drug development research practices to pursue a robust range of prescription drug treatments for CNS indications.
The delivery technologies, used in both oral and inhaled FDA-approved prescription drug products, represent a validated, strategic approach to overcoming traditional challenges of cannabinoid medicine. Receptor’s patented product candidates hold the potential to provide prescription treatments for a range of unmet medical needs, including anxiety and agitation in autism.
More information is at www.ReceptorLife.com.
- Industry Pharmaceutical Manufacturing
- Website https://receptorlife.com/
- LinkedIn https://www.linkedin.com/company/receptor-life-sciences-inc./
Related People
Mark TheeuwesFounder
United States -
Greater Philadelphia
Experienced Pharmaceutical Executive with a demonstrated history of working in all aspects of Clinical and Commercial Execution.
Brellium | $13,700,000 | (Apr 22, 2025)
Spur | $4,500,000 | (Apr 22, 2025)
Cosmic Robotics | $4,000,000 | (Apr 22, 2025)
Capsule | $12,000,000 | (Apr 22, 2025)
Kenzo Security | $45,000,000 | (Apr 22, 2025)
Electra.aero | $115,000,000 | (Apr 22, 2025)
ROH | $9,000,000 | (Apr 22, 2025)
Booked it | $3,316,375 | (Apr 18, 2025)
Exaforce Inc. | $75,000,000 | (Apr 18, 2025)